| Market Capitalization (Millions $) |
374 |
| Shares
Outstanding (Millions) |
61 |
| Employees |
276 |
| Revenues (TTM) (Millions $) |
87 |
| Net Income (TTM) (Millions $) |
-91 |
| Cash Flow (TTM) (Millions $) |
4 |
| Capital Exp. (TTM) (Millions $) |
4 |
Personalis Inc
Personalis Inc is a biotechnology company based in California, United States. The company specializes in advanced genomics and precision medicine, providing genomic sequencing and analysis solutions to support the development of personalized therapies and precision diagnostics.
Personalis uses its proprietary ACE (Accuracy and Content Enhanced) technology to generate accurate and comprehensive genomic data, which can help researchers and healthcare professionals in the discovery and development of therapies. The company's technology can analyze complex genomes, including cancer genomes, and provides insights into disease biology, immune response, and drug sensitivity.
Personalis also offers a range of services, including cancer genomics, clinical genetics, and population genomics. Their services help researchers and clinicians understand the individual variations in genome sequences and interpret their impact on health conditions and diseases.
The company has partnerships with pharmaceutical and biotech companies, academic institutions, and research organizations to collaborate on various genomics research projects. It has a strong focus on translating genomic data into actionable information that can improve patient care and outcomes.
Overall, Personalis Inc plays a crucial role in advancing precision medicine by leveraging genomic analysis to provide personalized insights into disease biology and treatment options.
Company Address: 6600 Dumbarton Circle Fremont 94555 CA
Company Phone Number: 752-1300 Stock Exchange / Ticker: NASDAQ PSNL
|
61.06 %